The daily chart of HCA shows a corrective downtrend after peaking at an all-time high of 556.52 in mid-March. Over the past month, the stock has declined 3.26%, with a steeper drop in the last week at 2.84%. This follows stabilization near 290 earlier in the year, within a broader yearly gain of 28.52%. The price action reflects a shift from bullish sector rotation into healthcare to post-earnings selling pressure, with the stock now testing lower trendline support.
Critical support lies at the classic pivot S1 of 427, followed by S2 at 416.20 and S3 at 409.93. Fibonacci pivots align closely, reinforcing 416-422 as a demand zone. Overhead resistance starts at R1 444.08, R2 450.34, and extends to prior consolidation near 461. Recent ideas highlighted 450-455 as a key zone prior to the breakdown, now flipped to resistance. A 52-week range of 321.39-556.52 underscores the multi-month uptrend's depth.
HCA trades below its key moving averages, signaling bearish control. The 5-day SMA sits at 461.86, 20-day at 470.78, 50-day around 479.92, and 200-day SMA at 489.22—all issuing sell signals. Exponential averages are similarly bearish, with EMA20 at 470.07 and EMA200 near 491.04. Price action below the 20-day SMA confirms the short-term downtrend, while distance from the 200-day suggests room for mean reversion if support holds.
Momentum has turned decisively bearish. RSI(14) plunged to 20.92, firmly oversold and contrasting earlier neutral readings around 58. STOCHRSI(14) at 12.92 also oversold, while STOCH(9,6) at 74.12 offers a lone buy amid the weakness. MACD(12,26) at -6.63 with negative histogram reinforces downside pressure. CCI(14) at -259 indicates extreme oversold territory, where traders often watch for divergence.
Recent sessions saw elevated volume, with over 3 million shares traded amid the 8.66% drop post-Q1 results. This confirms institutional selling during the breakdown from 474 previous close. Over the last 30 days, HCA consolidated before accelerating lower, forming lower highs in a potential Head & Shoulders pattern noted in community analysis. The quarterly view shows a 22% retracement from the March peak, testing demand zones amid higher volatility (ATR 7.63).
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast market data, including technical indicators, price patterns, and historical trends for stocks like HCA. These signals identify potential buy or sell opportunities by detecting momentum shifts, breakouts, and reversals through machine learning models trained on decades of chart behavior. Traders rely on them to pinpoint entry/exit points, validate trend strength, and enhance decision-making amid volatile conditions. Explore the signals for actionable insights tailored to current market dynamics.
Traders eye the 427-416 support cluster for signs of exhaustion or further downside. A bounce could target 444-450 resistance, where moving averages converge. Breakdown below 416 risks deeper correction toward 410 or prior lows. Monitor RSI for bullish divergence and MACD histogram for momentum shifts. Volume confirmation on any reversal will be crucial in this oversold setup within the longer-term uptrend.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, HCA has been closely correlated with UHS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To HCA | 1D Price Change % |
|---|---|---|
| HCA | 100% | +2.29% |
| HCA (2 stocks) | 96% Closely correlated | +0.23% |
| Hospital/Nursing Management (51 stocks) | 38% Loosely correlated | +0.19% |